The active ingredient in the popular diabetes and obesity drugs Ozempic and Wegovy could be linked to a drop in opioid overdoses, a study published in JAMA Network Open found. Why it matters: It's the latest evidence that buzzy drugs known as GLP-1s could be used to address psychiatric disorders,

The breakthrough diabetes drug Ozempic may lower the risk of opioid overdoses in certain patients, according to a new study published Wednesday, signaling that the wonder drug may eventually be used as an alternative form of treatment for opioid use disorder.